This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Dermatol. 1993;129(9):1096-1097.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Surveillance for Lyme disease (LD) was initiated by CDC in 1982,¹ and in 1990, the Council of State and Territorial Epidemiologists (CSTE) approved a resolution making LD nationally reportable. During 1982-1991, states reported 40,195 cases of LD. In 1992, LD accounted for more than 90% of all reported vectorborne illnesses in the United States (CDC, unpublished, 1993). This report summarizes surveillance for LD in the United States during 1991-1992.

Forty-nine states and the District of Columbia require reporting of LD. The CSTE/CDC surveillance case definition requires the presence of an erythema migrans rash or at least one objective sign of musculoskeletal, neurologic, or cardiovascular disease and laboratory confirmation of infection.²

During 1991, 47 states reported 9465 cases of LD to CDC³; during 1992,45 states reported a provisional total of 9677 cases, representing a 19-fold increase over the 497 cases reported by 11 states in 1982.¹ Most . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?